menu search

What the all-electric cadillac lyriq means for gm stock

General Motors has started retail production of its all-electric luxury crossover vehicle, the Cadillac Lyriq. The company is...

March 22, 2022, 8:13 am

Bridgebio: potential based on diverse pipeline targeting kras mutations and rare diseases

BridgeBio: Potential Based On Diverse Pipeline targeting KRAS Mutations And Rare Diseases...

March 22, 2022, 3:19 am

Fifth third shifting into higher gear as rates and the economy ramp up

Fifth Third is following a sound growth strategy, targeting both commercial and consumer business in fa...

March 17, 2022, 4:26 pm

South korea approves rules on app store law targeting apple, google

CNBC's Steve Kovach reports South Korea has approved rules on an app store law that targets Apple and Google....

March 15, 2022, 12:35 pm

Alphabet or amazon: which split am i buying?

So which stock split am I targeting for my portfolio? Let's take a look....

March 12, 2022, 11:30 am

Nemaura medical: opportunity in the consumer-centered continuous glucose monitoring market

The Continuous Glucose Monitoring Market is expanding to consumer-centered CGM wellness devices, targeting ...

March 10, 2022, 9:40 am

Op-ed: apple and google are spelling the end for user-tracking, and advertisers must adjust, says taboola ceo.

In a future where tracking users is much harder, the most logical and viable option for advertiser success is contextual targeting, argues Taboola CEO...

March 7, 2022, 6:17 pm

Regulus therapeutics announces timing for fourth quarter and year-end 2021 financial results webcast and conference call

SAN DIEGO, March 3, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and developme...

March 3, 2022, 5:15 pm

Regulus therapeutics announces timing for fourth quarter and year-end 2021 financial results webcast and conference call

SAN DIEGO, March 3, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and developme...

March 3, 2022, 5:15 pm

Regulus therapeutics announces timing for fourth quarter and year-end 2021 financial results webcast and conference call

SAN DIEGO, March 3, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and developme...

March 3, 2022, 5:15 pm

Oceanfirst looking to disrupt large, new loan markets and generate significant operating leverage

OceanFirst had a challenging 2021, but the bank exits 2021 with above-average loan growth momentum, ongoing cost-reduction plans, and an expanded lend...

March 3, 2022, 4:41 pm

Oceanfirst looking to disrupt large, new loan markets and generate significant operating leverage

OceanFirst had a challenging 2021, but the bank exits 2021 with above-average loan growth momentum, ongoing cost-reduction plans, and an expanded lend...

March 3, 2022, 4:41 pm

Oceanfirst looking to disrupt large, new loan markets and generate significant operating leverage

OceanFirst had a challenging 2021, but the bank exits 2021 with above-average loan growth momentum, ongoing cost-reduction plans, and an expanded lend...

March 3, 2022, 4:41 pm

Forget commodities: try merger arbitrage instead

As investors continue to flock toward commodities and other well-known inflation hedges, investors may be missing out on an especially well-positioned...

March 2, 2022, 3:07 pm

Forget commodities: try merger arbitrage instead

As investors continue to flock toward commodities and other well-known inflation hedges, investors may be missing out on an especially well-positioned...

March 2, 2022, 3:07 pm

Forget commodities: try merger arbitrage instead

As investors continue to flock toward commodities and other well-known inflation hedges, investors may be missing out on an especially well-positioned...

March 2, 2022, 3:07 pm

Beigene: oncological engineering set to break boundaries

BeiGene develops drugs designed to fight cancer using molecular targeting and immuno-oncology technolog...

March 2, 2022, 12:38 pm

Beigene: oncological engineering set to break boundaries

BeiGene develops drugs designed to fight cancer using molecular targeting and immuno-oncology technolog...

March 2, 2022, 12:38 pm

Beigene: oncological engineering set to break boundaries

BeiGene develops drugs designed to fight cancer using molecular targeting and immuno-oncology technolog...

March 2, 2022, 12:38 pm

Target is targeting growth

Target Corp. ( TGT , Financial) announced on Tuesday it plans to invest up to $5 billion to continue scaling its operations in 2022....

March 2, 2022, 10:26 am


Search within

Pages Search Results: